Case: Carmat SA
Lifetec news

Case: Carmat SA

"Carmat is the designer and developer of the world’s most advanced total artificial heart. With this product, they aim to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure." 

PAPER: "REAL-TIME PHOTOACOUSTIC ASSESSMENT OF RADIOFREQUENCY ABLATION LESION FORMATION IN THE LEFT ATRIUM"
Lifetec news

PAPER:

A new paper has been published by a clinical research group in the Erasmus Medical Center in Rotterdam, the Netherlands, entitled: “Real-time photoacoustic assessment of radiofrequency ablation lesion formation in the left atrium".

Read more >>

News | Paper: "Investigating the physiology of normothermic ex vivo heart perfusion in an isolated slaughterhouse porcine model used for device testing and training"
Lifetec news

Paper: "Investigating the physiology of normothermic ex vivo heart perfusion ..."

We report on a study into the physiology of our PhysioHeart™ platform that was conducted to identify ideas to further improve our beating heart model.

28th Annual meeting of the Netherlands society of Biomaterials and Tissue Engineering
Lifetec news

28th Annual meeting of the Netherlands society of Biomaterials and Tissue Engineering

The 21st and the 22nd of November LifeTec Group's Martina Puricelli will attend the 28th Annual meeting of the Netherlands society of Biomaterials and Tissue Engineering, in Lunteren. 

 LifeTec Group and Biotest Facility aim to reduce animal testing
Lifetec news

LifeTec Group and Biotest Facility aim to reduce animal testing

Medicine affects your body. That’s a good thing, that’s how it makes you feel better or even cures you, but most of the time the intended purpose is not the only effect:  >>

Vascular Bioreactor: Scientific Paper Now Available!!
Lifetec news

Vascular Bioreactor: Scientific Paper Now Available!!

Make the artery feel at home”, this is the main topic of the brand-new paper >>

Meet us at CompBioMed Conference 2019, 25-27 September, London
Lifetec news

Meet us at CompBioMed Conference 2019, 25-27 September, London

The conference will address all aspects of the rapidly burgeoning domain of computational biomedicine, from genome through organ to whole human and population levels, embracing data driven, mechanistic modelling and simulation, machine learning and combinations thereof.

First Coronary Artery Study in LifeTec Group's Vascular Bioreactor
Lifetec news

First Coronary Artery Study in LifeTec Group's Vascular Bioreactor

A new milestone for LifeTec Group’s vascular bioreactor platform has recently been achieved: a pilot study using porcine coronary arteries has been successfully performed! 

AngioSupport, designed to offer cardiologists better insights
Lifetec news

AngioSupport, designed to offer cardiologists better insights

Tim van den Boom and Bettine van Willigen are currently doing a two-year PDEng doctorate degree for Qualified Medical Engineer. They’re working on an interactive tool called AngioSupport, designed to offer cardiologists better insights into the impact of their decisions when treating coronary artery occlusions. -->>

First Human Heart study at LifeTec Group’s lab!
Lifetec news

First Human Heart study at LifeTec Group’s lab!

In LifeTec Group’s lab facility in Eindhoven, the first study using human cadaveric hearts has been very successfully conducted on the Cardiac Biosimulator Platform -->>

Pages

Get in touch

Please do not hesitate to contact LifeTec Group if you require any further information:

Contact

©2020 LifeTec Group.  Legal  Credits